Anticonvulsant Activity of B2, an Adenosine Analog, on Chemical Convulsant-Induced Seizures

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Li, Min ^a,b   Kang, Ruixia ^a   Shi, Jiangong ^a   Liu, Gengtao ^a   Zhang, Jianjun ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b BEIJING HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOPYRIDINE; 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE DERIVATIVE; B 2; CARBAMAZEPINE; CONVULSANT AGENT; CYCLIC AMP; DIAZEPAM; KAINIC ACID; N6 (3 METHOXYL 4 HYDROXYBENZYL) ADENINE RIBOSIDE; PENTETRAZOLE; PICROTOXIN; PROTEIN C FOS; RADIOLIGAND; STRYCHNINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DRUG ANTAGONISM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; ENZYME ASSAY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LATENT PERIOD; LIGAND BINDING; MALE; MORTALITY; MOUSE; NERVE CELL EXCITABILITY; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT; SEIZURE; STRUCTURE ANALYSIS; WESTERN BLOTTING;

ADENOSINE; ADENOSINE A1 RECEPTOR ANTAGONISTS; ANIMALS; ANTICONVULSANTS; CONVULSANTS; CYCLIC AMP; GENE EXPRESSION REGULATION; MALE; MICE; NEURONS; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTOR, ADENOSINE A1; RECEPTOR, ADENOSINE A2A; SEIZURES;

MUS; STRYCHNOS TOXIFERA;

EID: 84879332651     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067060     Document Type: Article

References (47)

1. Sander JWAS, Shorvon SD, (1996) Epidemiology of epilepsies. J Neurol Neurosurg Psychiatry 61: 433-443.
2. Smith MC, Bleck TP, (1991) Convulsive Disorders: toxicity of anticonvulsants. Clin Neuropharmacol 14: 97-115.
3. Chin JH, (1989) Adenosine receptors in brain: neuromodulationand role in epilepsy. Ann Neurol 26: 695-698.
4. Malhotra J, Gupta YK, (1997) Effect of adenosine receptor modulation on pentylenetetrazole-induced seizures in rats. Br J Pharmacol 120(2): 282-288.
5. Fredholm BB, (2003) Adenosine receptors as targets for drug development. Drug News Perspect 16: 283-289.
6. Yan L, Burbiel JC, Maass A, Müller CE, (2003) Adenosine receptor agonists: from basic medicinal chemistry to clinical development. Expert Opin Emerg Drugs 8: 537-536.
7. Kim SK, Gao ZG, Van Rompaey P, Gross AS, Chen A, et al. (2003) Modelling the adenosine receptors: Comparison of binding domains of A2A agonist and antagonist. J Med Chem 46: 4847-4859.
8. Tchilibon S, Joshi BV, Kim SK, Duong HT, Gao ZG, et al. (2005) (N)-Methanocarba-2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists. J Med Chem 48: 1745-1758.
9. Jacobson KA, Gao ZG, (2006) Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 5: 247-264.
10. Sun J, Li M, Kang RX, Yue ZG, Shi JG, et al. (2011) Protective effect of new adenosine analog B2 against serum deprivation-induced PC12 cell injury. Yao Xue Xue Bao. 46(10): 1199-203 (in Chinese).
11. Klotz KN, Lohse MJ, Schwabe U, Cristalli G, Vittori S, et al. (1989) 2-Chloro-N6-[3H]cyclopentyladenosine ([3H]CCPA)-a high affinity agonist radioligand for A1 adenosine receptors. Naunyn Schmiedebergs Arch of Pharmacol 340: 679-683.
12. Müller CE, Maurinsh J, Sauer R, (2000) Binding of [3H]MSX-2(3-(3-hydroxypropyl)- 7-methyl-8-(m-methoxystyryl)-1-propargylxanthine) to rat striatal membranes - a new, selective antagonist radioligand for A2A adenosine receptors. Eur J Pharm Sci 10: 259-265.
13. Cheng Y, Prusoff WH, (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22: 3099-3108.
14. Nordstedt C, Fredholm BB, (1990) A modification of a protein-binding method for rapid quantification of cAMP in cell-culture supernatants and body fluid. Anal Biochem 189: 231-234.
15. Marsh DJ, Hollopeter G, Kafer KE, Palmiter RD, (1998) Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nat Med 4: 718-721.
16. Racine RJ (1972) Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroenceph. Clin Neurophysiol 32, 281-294.
17. Sherin JE, Shiromani PJ, McCarley RW, Saper CB, (1996) Activation of ventrolateral preoptic neurons during sleep. Science 271: 216-219.
18. Londos C, Cooper DM, Wolff J, (1980) Subclasses of external adenosine receptors. Proc Natl Acad Sci USA 77: 2551-2554.
19. Van Calker D, Müller M, Hamprecht B, (1979) Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J Neurochem 33: 999-1005.
20. Kenakin T, (1996) The classification of seven transmembrane receptors in recombinant expression systems. Pharmacol Rev 48: 413-463.
21. Loscher W, Schmidt D, (1988) Which animal models should be used inthe search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res 988 2: 145-181.
22. Engel J Jr, Williamson PD, Wieser HG (1997) Mesial temporal lobe epilepsy. In: Engel J Jr, Pedley J, editors. Epilepsy: a comprehensive textbook. New York: Raven Press. 2417-2426.
23. Nadler JV, (1981) Kainic acid as a tool for the study of temporal lobe epilepsy. Life Sci 29: 2031-2042.
24. Schrader J, Wahl M, Kuschinsky W, Kreutzberg GW, (1980) Increase of adenosine content in cerebral cortex of the cat during bicuculline-induced seizure. Pflugers Arch 387: 245-251.
25. Gouder N, Fritschy JM, Boison D, (2003) Seizure suppression by adenosine A1 receptor activation in a mouse model of pharmacoresistant epilepsy. Epilepsia 44: 877-885.
26. Li T, Quan Lan J, Fredholm BB, Simon RP, Boison D, (2007) Adenosine dysfunction in astrogliosis: cause for seizure generation? Neuron Glia Biol 3(4): 353-366.
27. Fedele DE, Li T, Lan JQ, Fredholm BB, Boison D, (2006) Adenosine A1 receptors are crucial in keeping an epileptic focus localized. Exp Neurol 200(1): 184-190.
28. Huber A, Güttinger M, Möhler H, Boison D, (2002) Seizure suppression by adenosine A(2A) receptor activation in a rat model of audiogenic brainstem epilepsy. Neurosci Lett 329: 289-292.
29. Zeraati M, Mirnajafi-Zadeh J, Fathollahi Y, Namvar S, Rezvani ME, (2006) Adenosine A1 and A2A receptors of hippocampal CA1 region have opposite effects on piriform cortex kindled seizures in rats. Seizure 15: 41-48.
30. De Sarro G, De Sarro A, Di Paola ED, Bertorelli R, (1999) Effects of adenosine receptor agonists and antagonists on audiogenic seizure-sensible DBA/2 mice. Eur J Pharmacol 371(2-3): 137-45.
31. Ste{ogonek}pień KM, Tomaszewski M, Tomaszewska J, Czuczwar SJ, (2002) The multidrug transporter P-glycoprotein in pharmacoresistance to antiepileptic drugs. Pharmacol Rep 64(5): 1011-9.
32. Sisodiya SM, Lin WR, Harding BN, Squier MV, Thom M, (2002) Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy. Brain 125(Pt 1): 22-31.
33. Boison D, (2005) Adenosine and Epilepsy: From Therapeutic Rationale to New Therapeutic Strategies. Neuroscientist 11: 25-36.
34. Pagonopoulou O, Efthimiadou A, Asimakopoulos B, Nikolettos NK, (2006) Modulatory role of adenosine and its receptors in epilepsy: possible therapeuticapproaches. Neurosci Res 56(1): 14-20.
35. Huber A, Güttinger M, Möhler H, Boison D, (1993) Seizure suppression by adenosine A(2A) receptor activation in a rat model of audiogenic brainstem epilepsy. Br J Pharmacol 110(1): 470-476.
36. MacGregor DG, Miller WJ, Stone TW, (2002) Mediation of the neuroprotective action of R-phenylisopropyl-adenosine through a centrally located adenosine A1 receptor. Neurosci Lett 6 329(3): 289-292.
37. De Sarro G, De Sarro A, Di Paola ED, Bertorelli R, (1999) Effects of adenosine receptor agonists and antagonists on audiogenic seizure-sensible DBA/2 mice. Eur J Pharmacol 371(2-3): 137-145.
38. Gouder N, Fritschy JM, Boison D, (2003) Seizure suppression by adenosine A1 receptor activation in a mouse model of pharmacoresistant epilepsy. Epilepsia. 44(7): 877-885.
39. Boison D, Scheurer L, Tseng JL, Aebischer P, Mohler H (1999) Seizure suppression in kindled rats by intraventricular grafting of an adenosine releasing synthetic polymer. Exp Neurol 160, 164-174.
40. Uzbay TI, Kayir H, Ceyhan M, (2007) Effects of tianeptine on onset time of pentylenetetrazole-induced seizures in mice: possible role of adenosine A1 receptors. Neuropsychopharmacology 32(2): 412-416.
41. Masino SA, Kawamura M, Wasser CD, Pomeroy LT, Ruskin DN, (2009) Adenosine, Ketogenic Diet and Epilepsy: The Emerging Therapeutic Relationship Between Metabolism and Brain Activity. Curr Neuropharmacol. 7(3): 257-268.
42. Dragunow M, Robertson HA, (1987) Kindling stimulation induces c-fos protein(s) in granule cells of the rat dentate gyrus. Nature 329: 441-442.
43. Dragunow M, Yamada N, Bilkey DK, Lawlor P, (1992) Induction of immediate-early gene proteins in dentate granule cells and somatostatin interneurons after hippocampal seizures. Mol Brain Res 13: 119-126.
44. Morgan JI, Cohen DR, Hempstead JL, Curran T, (1987) Mapping patterns of c-fos expression in the central nervous system after seizure. Science 237: 192-197.
45. Jaworski J, Biedermann IW, Lapinska J, Szklarczyk A, Figiel I, et al. (1999) Neuronal excitation-driven and AP-1-dependent activation of tissue inhibitor of metalloproteinases-1 gene expression in rodent hippocampus. J Biol Chem 274(40): 28106-28112.
46. Bao YY, Ding MP, (2002) C-Fos expression in the hippocampus of rats with pentylenetetrazol-induced epilepsy. Zhejiang Da Xue Xue Bao Yi Xue Ban 31(2): 111-114.
47. Peng Z, Houser CR, (2005) Temporal patterns of fos expression in the dentate gyrus after spontaneous seizures in a mouse model of temporal lobe epilepsy. J Neurosci 3 25(31): 7210-7220.